"Somatic" and "pathogenic" - is the classification strategy applicable in times of large-scale sequencing?
Haematologica
.
2019 Aug;104(8):1515-1520.
doi: 10.3324/haematol.2019.218917.
Epub 2019 Jul 4.
Authors
Constance Baer
1
,
Wencke Walter
1
,
Stephan Hutter
1
,
Sven Twardziok
1
,
Manja Meggendorfer
1
,
Wolfgang Kern
1
,
Torsten Haferlach
2
,
Claudia Haferlach
1
Affiliations
1
MLL Munich Leukemia Laboratory, Munich, Germany.
2
MLL Munich Leukemia Laboratory, Munich, Germany torsten.haferlach@mll.com.
PMID:
31273095
PMCID:
PMC6669162
DOI:
10.3324/haematol.2019.218917
No abstract available
MeSH terms
Genetic Variation*
High-Throughput Nucleotide Sequencing
Humans
Neoplasms / classification*
Neoplasms / genetics
Sequence Analysis, DNA